Cargando…
Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL)
OBJECTIVES: Patient experiences are critical when determining the acceptability of novel interventional pharmaceuticals. Here, we report the development and validation of a product acceptability questionnaire (SPRAY PAL) assessing feasibility, acceptability and tolerability of an intranasal Q-Griffi...
Autores principales: | Cash, Elizabeth, Deitz, Kailyn, Potts, Kevin L, Nabeta, Henry W, Zahin, Maryam, Rai, Shesh N, Dryden, Gerald W, Palmer, Kenneth E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503384/ https://www.ncbi.nlm.nih.gov/pubmed/37699630 http://dx.doi.org/10.1136/bmjopen-2023-073735 |
Ejemplares similares
-
Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin
por: Nabeta, Henry W., et al.
Publicado: (2021) -
Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis
por: Nabeta, Henry W., et al.
Publicado: (2022) -
Mechanism of Action of Lung Damage Caused by a Nanofilm Spray Product
por: Larsen, Søren T., et al.
Publicado: (2014) -
Study protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15)
por: Matsuda, Yoshinobu, et al.
Publicado: (2021) -
Bulk production of the antiviral lectin griffithsin
por: Fuqua, Joshua L., et al.
Publicado: (2015)